The Jean Hailes Foundation for Women's Health

Contact UsFeedbackGlossaryLinksMagazineMediaPrivacyShopSite Map

Main Menu
Home
About the Foundation
Volunteer
Research Unit
Medical Centre
Education Unit
Community Webcast
Events
Fact Sheets
Resources
Community Groups
Rural and Remote
Multilingual Info
Hot Topics
GPs and Health Professionals
For GPs & HPs
GP & HP Updates
Talking Women
Prof Development
Prof Dev Events
Links for GPs & HPs
Research
Resources
National Magazine
About our Magazine
Feature articles
Recipes index
2008-9 Summer
2008 Winter
2007-8 Summer
2007 Winter
Archive Editions
Media Centre
Media Contact
2008 Releases
Archive Releases
Members Login





Lost Password?
No account yet? Register

Visit the Jean Hailes Foundation for Womens Health Shop

Get Acrobat Reader

Home arrow Hot Topics arrow 2005 Topics arrow 2005 - Hormones and endometrial cancer – UK study inconclusive
2005 - Hormones and endometrial cancer – UK study inconclusive Print E-mail

A message to Australian women concerned by a recent UK study connecting hormone therapy with endometrial cancer

The Jean Hailes Foundation for Women's Health is closely monitoring the coverage of a controversial study1 from the UK relating to menopause and cancer risk.

Here at the Foundation, we are always reading and analysing information from medical researchers around the world. We are driven to offer accurate and reassuring advice to you regarding safe and healthy use of medications.

With this in mind, the Foundation’s Director of Research, Dr Helena Teede, has questioned the quality of a new report from the UK, connecting hormone therapy with womb cancer in some women.

Dr Teede has strongly endorsed the very comprehensive guidelines on hormone therapy (HT) provided by the Federal Government’s independent medical advisory body, the NHMRC.

“Basically, we advise Australian women to use the lowest dose of hormone therapy for the shortest duration to relieve symptoms at the time of menopause,” Dr Teede said. "Doctors should continue prescribing minimal doses of hormone therapy for the shortest possible times."

Dr Teede and her research collaborators at the Jean Hailes Foundation for Women's Health believe results from the UK Million Women Study need to be interpreted with caution as they could be misleading - and while interesting at a research level, “are not in any way definitive”.

Dr Teede was responding to the study published by a medical journal, The Lancet, which claims certain types of hormone-replacement therapy increase some women’s risk of womb cancer.

“The Jean Hailes Foundation for Women's Health strongly supports The Lancet’s editorial which calls for continued, careful use of HT to relieve symptoms while minimising risks,” Dr Teede said.

If you are still worried, the Foundation suggests you visit your doctor and discuss your concerns.

Reference

1.Endometrial cancer and hormone-replacement therapy in the Million Women Study,
The Lancet, Vol 365, April 30, 2005. pp 1543-51
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=15866308)

Content updated April 29, 2005

Last Updated ( Saturday, 22 December 2007 )
 
The Jean Hailes Foundation for Women's Health
Jean Hailes Foundation
Ageing Well
Bone Health for Life
Early Menopause
Endometriosis
Health for Women
Managing Menopause
Managing PCOS
Online GP & HP Education
Support the foundation: Donate here
Events Calendar
S M T W T F S
282930311 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31


We comply with the HONcode standard for health trust worthy information: verify here.
HealthInsite HealthInsite
Better Health Channel Better Health Channel

 

Website by Impagination